Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | IL2-Ra | 13.5 | 36 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 16.0 | 70 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 14.0 | 91 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 17.0 | 66 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 13.0 | 62 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 17.0 | 76 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 15.0 | 70 | |
RA2159 | EO1428 | 1.0 | uM | 1 | IL2-Ra | 14.5 | 68 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 18.0 | 50 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 19.0 | 32 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 21.0 | 42 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 23.0 | 67 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 17.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL2-Ra | 22.0 | 43 | |
N2586 | EO1428 | 1.0 | uM | 1 | IL2-Ra | 17.0 | 68 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 19.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 20.0 | 80 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 16.0 | 49 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 20.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 21.0 | 62 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 17.5 | 56 | |
RA2159 | PI103 | 0.1 | uM | 1 | IL2-Ra | 14.0 | 60 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 21.5 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 23.0 | 45 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL2-Ra | 22.0 | 57 |